Liquid medicine mixing sprayer

Abstract

The invention relates to a liquid medicine mixing sprayer which comprises injectors, a tee joint and a mixing spray head, wherein the front parts of the main injector and the auxiliary injector are connected with the mixing spray head through the tee joint, and the rear parts of core rods of the injectors are provided with a synchronizing pushing handle. A mixing cavity of the mixing sprayed head is internally provided with a spray core column, and the port of the spray core column is provided with an atomization sheet which is buckled on the spray core column. A growth factor product and coagulant are respectively stored in the main injector and the auxiliary injector, enter the mixing spray head according to the proportion, and are sprayed out by the atomization sheet. The invention is convenient for mixing the medicine, shortens the mixing time of the growth factor product and the coagulant, avoids the flocculation, and can make the liquid medicine be uniformly sprayed on wound in a vapourous state. The invention has simple structure, convenient operation and use, high working efficiency and good safety performance.

Description

technical field [0001] The invention relates to a medical device, in particular to a medicinal liquid mixing sprayer. Background technique [0002] As we all know, in the clinical wound healing process, growth factor products are often mixed with blood coagulation drugs and applied to the wound, which can speed up healing and reduce scars. The traditional mixing method is to mix two different substances by stirring, and then smear it on the wound, or put the mixed solution in a sprayer and spray it on the wound. This process is prone to secondary infection, and after the growth factor product is mixed with the coagulation drug, flocculation occurs in a short period of time, resulting in uneven mixing, which is not conducive to the growth factor's role. In addition, it is difficult to apply the growth factor evenly in the process of applying it to the wound, and the operation process is difficult to control, which often brings additional pain to the patient. Contents of th...

AI Technical Summary

Problems solved by technology

This process is prone to secondary infection, and after the growth factor product is mixed with the coagulation drug, flocculation occurs in a short period of time, resulting in uneven stirring, which is not conducive to the role of growth factor

In addition, it is difficult to apply growth factors evenly in the process of applying to the wound, and the operation process is difficult to control, which often brings additional pain to the patient

Images